Skip to content

Early Blood Purification on Acute Paraquat Poisoning: a Multicenter Prospective Cohort Study

Early Blood Purification on Acute Paraquat Poisoning: a Multicenter Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006681
Enrollment
Unknown
Registered
2015-07-02
Start date
2015-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute poisoning

Interventions

hemoperfusion group (HP group):conventional therapy and hemoperfusion
HP+CVVH grop:conventional therapy and hemoperfusion +CVVH

Sponsors

Beijing Chao-Yang Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 64 Years

Inclusion criteria

Inclusion criteria: (1) oral ingestion of paraquat poisoning patients; (2) Age> 14 years; (3) the date of admission from the poison time <24 hours; (5) signed informed consent.

Exclusion criteria

Exclusion criteria: (1) PQ poisoning patients received another blood purification treatment before; (2) associated with other toxic poisoning; (3) of heparin allergy; (4)heparin-induced thrombocytopenia, HIT; (5)significant bleeding tendencies; (6) preexisting severe heart, lung, liver, kidney and blood diseases; (7) pregnancy, breast-feeding patients; (8) dying state.

Design outcomes

Primary

MeasureTime frame
blood concentration of paraquat;SOFA;Survival time;

Countries

China

Contacts

Public ContactWenxiong LI
lwx7115@sina.com+86 13601097813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026